In this free webinar, learn about the rapidly growing cell and gene therapy and vaccine markets. Attendees will get an overview of the manufacturing process for adeno-associated virus (AAV) and how Akron Bio’s new facility is designed to address the serious industry issues around capacity, scalability, and quality. The featured speakers will discuss the latest information from regulators on how plasmid DNA (pDNA) quality should be assessed, creating a guideline for manufacturers to work to.
(PRWeb October 28, 2022)
Read the full story at https://www.prweb.com/releases/meeting_the_increasing_manufacturing_demands_of_the_rapidly_growing_cell_and_gene_therapy_and_vaccine_markets_upcoming_webinar_hosted_by_xtalks/prweb18986112.htm
For more information, please visit
https://www.prweb.com/releases/meeting_t[...]ed_by_xtalks/prweb18986112.htm